Youngjin Pharm reports operating loss of 13.8 billion KRW last year, turning to deficit

[Asia Economy Reporter Hwang Junho] Youngjin Pharmaceutical announced on the 10th that its operating profit on an individual basis last year was 13,877,510,000 KRW, resulting in a loss and a turnaround to a deficit compared to the previous year. During the same period, sales decreased by 5.9% to 196,067,240,000 KRW. The net loss for the period widened to 11,582,460,000 KRW.

This content was produced with the assistance of AI translation services.